WASHINGTON (Reuters) – The White House on Wednesday pushed back against press reports that Federal Drug Administration commissioner Stephen Hahn had been called to the White House to explain delays in approving a Pfizer coronavirus vaccine, noting that such meetings are routine.
“What I will say about Dr. Hahn is, it is par for the course for the Chief of Staff to meet with him as we’re trying to save American lives with the vaccine in record time,” White House Press Secretary Kayleigh McEnany said, regarding a meeting between Hahn and White House Chief of Staff Mark Meadows that Axios reported took place on Tuesday.
(This story corrects spelling of Hahn’s first name in first paragraph.)
(Reporting by Andrea Shalal, Editing by Franklin Paul)
